Company Shares of Amyris Drops by -2.36%

Amyris (NASDAQ:AMRS) has tumbled 2.36% during the past week and has dropped 5.88% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 1.19%. Amyris (NASDAQ:AMRS) has underperformed the index by 6.74% in the last 4 weeks. Investors should watch out for further signals and trade with caution.

Amyris (NASDAQ:AMRS): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $0.51 and $0.51 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $0.55. The buying momentum continued till the end and the stock did not give up its gains. It closed at $0.51, notching a gain of 1.84% for the day. The total traded volume was 2,227,291 . The stock had closed at $0.50 on the previous day.

The company shares have dropped -73.30% from its 1 Year high price. On Jul 16, 2015, the shares registered one year high at $2.62 and the one year low was seen on Jun 16, 2016. The 50-Day Moving Average price is $0.64 and the 200 Day Moving Average price is recorded at $1.18.

On the companys insider trading activities, Doerr L John, director of Amyris, Inc., executed a transaction worth $208,600 on June 14, 2016. A total of 200,577 shares were purchased at an average price of $1.04. The Insider information was divulged by the Securities and Exchange Commission in a Form 4 filing. The information is based on open market trades at the market prices.Option exercises are not covered.

Many analysts have stated their opinion on the company shares. Brokerage firm Cowen & Company maintains its rating on Amyris (NASDAQ:AMRS). As per the latest information, the brokerage house lowers the price target to $2 per share from a prior target of $2.5. The shares have been rated Market Perform. The rating by the firm was issued on March 10, 2016. Currently the company Insiders own 48.7% of Amyris shares according to the proxy statements. Institutional Investors own 40.71% of Amyris shares.

Amyris, Inc. is a renewable products company. The Company is focused on providing sustainable alternatives to a range of petroleum-sourced products used in consumer care, specialty chemical and transportation fuel markets around the world. The Company developed microbial engineering and screening technologies that modify the way microorganisms process sugars. The Company using its industrial bioscience technology to design microbes, primarily yeast, and use them as living factories in established fermentation processes to convert plant-sourced sugars into renewable hydrocarbons. The Company has focused its commercialization efforts on a renewable hydrocarbon molecule called farnesene (Biofene), which forms the basis for a range of products including emollients, flavors and fragrance oils and diesel fuel.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.